Boston Scientific Corporation Share Price
Stocks
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
21:00:02 13/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 44.34 USD | +0.32% |
|
+3.72% | -53.50% |
| Market Cap | 64.27B 58.24B 53.87B 48.6B 91.6B 6,060B 94.82B 647B 257B 3,237B 241B 236B 10,275B | P/E 2026 * |
18.1x | P/E 2027 * | 19.3x |
|---|---|---|---|---|---|
| Enterprise Value | 74.75B 67.74B 62.66B 56.53B 107B 7,048B 110B 753B 298B 3,765B 281B 275B 11,952B | EV / Sales 2026 * |
3.57x | EV / Sales 2027 * | 3.43x |
| Free-Float |
82.46% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
|
London S.E.
| 0HOY | Delayed | |
|
Mexican S.E.
| BSX * | End-of-day quote | |
|
Tradegate
| BSX | Real-time | |
|
Börse Stuttgart
| BSX | Delayed | |
|
Boerse Muenchen
| BSX | Real-time | |
|
Xetra
| BSX | Delayed | |
|
Deutsche Boerse AG
| BSX | Delayed | |
|
CBOE
| Real-time | ||
|
Borsa Italiana
| 1BSX | End-of-day quote | |
|
Wiener Boerse
| BSXC | End-of-day quote | |
|
Swiss Exchange
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
CBOE
| 0HOY | Real-time | |
|
Bulgaria S.E.
| BSX | End-of-day quote |
Last Transcript: Boston Scientific Corporation
| 1 day | +0.32% | ||
| 1 week | +3.72% | ||
| Current month | +5.62% | ||
| 1 month | +3.12% | ||
| 3 months | -14.45% | ||
| 6 months | -17.20% | ||
| Current year | -53.50% |
| 1 week | 43.04 |  | 45.82 |
| 1 month | 39.57 | | 46.97 |
| Current year | 39.57 | | 100.9 |
| 1 year | 39.57 | | 102.7 |
| 3 years | 39.57 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 31/10/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 29/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 02/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 28/02/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 14/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/11/26 | Don | Chief Executive Officer | 252,241 | 0.0171% | ||
| 01/11/26 | Exercice | Head of Human Resources | 9,614 | 0.0007% | ||
| 25/08/26 | Buy | Director | 2,040 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.32% | +3.72% | -56.82% | -17.92% | 64.27B | |
| +0.11% | +0.79% | +21.00% | +52.47% | 259B | |
| +0.37% | +1.20% | +5.34% | +14.49% | 164B | |
| +0.84% | -2.03% | -19.28% | +52.11% | 154B | |
| +1.28% | +4.91% | +24.16% | +62.87% | 61.61B | |
| +0.34% | -1.59% | +0.18% | -11.25% | 53.94B | |
| +0.55% | -0.46% | +18.49% | +55.86% | 49.04B | |
| -0.29% | -0.72% | +2.78% | +73.84% | 48.82B | |
| -0.42% | +0.58% | +21.31% | +77.93% | 45.24B | |
| +1.44% | +0.78% | +13.49% | +14.97% | 37.54B | |
| Average | +0.45% | +0.72% | +3.07% | +37.54% | 94B | |
| Weighted average by Cap. | +0.41% | +0.58% | +3.97% | +38.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 20.97B 19B 17.58B 15.86B 29.88B 1,977B 30.94B 211B 83.72B 1,056B 78.69B 77.02B 3,352B | 20.88B 18.92B 17.5B 15.79B 29.75B 1,969B 30.8B 210B 83.36B 1,052B 78.35B 76.69B 3,338B |
| Net income | 3.53B 3.2B 2.96B 2.67B 5.03B 333B 5.21B 35.56B 14.1B 178B 13.25B 12.97B 565B | 3.27B 2.96B 2.74B 2.47B 4.66B 308B 4.83B 32.94B 13.06B 165B 12.28B 12.02B 523B |
| Net Debt | 10.48B 9.5B 8.79B 7.93B 14.94B 989B 15.47B 106B 41.86B 528B 39.35B 38.51B 1,676B | 7.39B 6.7B 6.19B 5.59B 10.53B 697B 10.9B 74.39B 29.5B 372B 27.73B 27.14B 1,181B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | US$44.34 | +0.32% | 9,700,017 |
| 12/11/26 | US$44.20 | -2.06% | 11,505,058 |
| 11/11/26 | US$45.13 | +0.96% | 17,786,952 |
| 10/11/26 | US$44.70 | +1.54% | 11,713,596 |
| 09/11/26 | US$44.02 | +2.97% | 16,195,827 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
